Hans Briem Selected Research

BAY 2315497

1/2021

BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans Briem Research Topics

Disease

8	Neoplasms (Cancer) 12/2021 - 07/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Lymphoma (Lymphomas) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Aneuploidy (Aneuploid) 01/2020
1	Genomic Instability 01/2020
1	Inflammation (Inflammations) 01/2020

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 06/2021 - 01/2019
1	Positive Transcriptional Elongation Factor BIBA 12/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2021
1	Adenosine Monophosphate (AMP)IBA 06/2021
1	AndrogensIBA 06/2021
1	Lipase (Acid Lipase)FDA Link 06/2021
1	ChromatinIBA 06/2021
1	Thorium-227IBA 01/2021
1	BAY 2315497IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2020
1	quinolineIBA 01/2020
1	BAY 1895344IBA 01/2020
1	Taxoids (Taxanes)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	olaparibIBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	atuveciclibIBA 11/2017
1	roniciclibIBA 07/2013

Therapy/Procedure

3	Therapeutics 12/2021 - 11/2017